Thomas C. Mckenzie

Array ( [id] => 6142242 [patent_doc_number] => 20020002168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-03 [patent_title] => 'Heterocyclic carboxamides' [patent_app_type] => new [patent_app_number] => 09/862691 [patent_app_country] => US [patent_app_date] => 2001-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12182 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20020002168.pdf [firstpage_image] =>[orig_patent_app_number] => 09862691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1068910 [patent_doc_number] => 06844436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-18 [patent_title] => 'Preparing pyrazolopyrimidinone derivatives for the treatment of impotence' [patent_app_type] => utility [patent_app_number] => 10/311397 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4274 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/844/06844436.pdf [firstpage_image] =>[orig_patent_app_number] => 10311397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1220933 [patent_doc_number] => 06703421 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-09 [patent_title] => 'Methods of using phenylmethylbenzoquinone and hydroquinone compounds for treatment of myocarditis, dilated cardiomyopathy and heart failure' [patent_app_type] => B1 [patent_app_number] => 09/856072 [patent_app_country] => US [patent_app_date] => 2001-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 48743 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/703/06703421.pdf [firstpage_image] =>[orig_patent_app_number] => 09856072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 999691 [patent_doc_number] => 06911542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-28 [patent_title] => 'Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivatives' [patent_app_type] => utility [patent_app_number] => 10/297682 [patent_app_country] => US [patent_app_date] => 2001-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9885 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/911/06911542.pdf [firstpage_image] =>[orig_patent_app_number] => 10297682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 699722 [patent_doc_number] => 07067653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-27 [patent_title] => 'Porphyrin Based neuton capture agents for cancer therapy' [patent_app_type] => utility [patent_app_number] => 10/258948 [patent_app_country] => US [patent_app_date] => 2001-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11842 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067653.pdf [firstpage_image] =>[orig_patent_app_number] => 10258948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1467310 [patent_doc_number] => 06458799 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'Deazaguanine analog, preparation thereof and use thereof' [patent_app_type] => B1 [patent_app_number] => 09/847998 [patent_app_country] => US [patent_app_date] => 2001-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3689 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458799.pdf [firstpage_image] =>[orig_patent_app_number] => 09847998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1596213 [patent_doc_number] => 06492358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-10 [patent_title] => '-carboline derivatives useful as inhibitors of phosphodiesterase' [patent_app_type] => B2 [patent_app_number] => 09/847767 [patent_app_country] => US [patent_app_date] => 2001-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15649 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 661 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492358.pdf [firstpage_image] =>[orig_patent_app_number] => 09847767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575157 [patent_doc_number] => 06468998 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Pyrrolidine compounds and medicinal utilization thereof' [patent_app_type] => B1 [patent_app_number] => 09/830718 [patent_app_country] => US [patent_app_date] => 2001-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17293 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 725 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468998.pdf [firstpage_image] =>[orig_patent_app_number] => 09830718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1500841 [patent_doc_number] => 06486150 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-11-26 [patent_title] => 'Process for formulation of antibiotic compounds' [patent_app_type] => B2 [patent_app_number] => 09/845453 [patent_app_country] => US [patent_app_date] => 2001-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6486 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/486/06486150.pdf [firstpage_image] =>[orig_patent_app_number] => 09845453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 999592 [patent_doc_number] => 06911443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-28 [patent_title] => 'Imidazopyrimidine derivatives and triazolopyrimidine derivatives' [patent_app_type] => utility [patent_app_number] => 10/258628 [patent_app_country] => US [patent_app_date] => 2001-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38060 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/911/06911443.pdf [firstpage_image] =>[orig_patent_app_number] => 10258628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1325688 [patent_doc_number] => 06602901 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-05 [patent_title] => 'Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)' [patent_app_type] => B2 [patent_app_number] => 09/835218 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29681 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 625 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602901.pdf [firstpage_image] =>[orig_patent_app_number] => 09835218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470352 [patent_doc_number] => 06407127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-06-18 [patent_title] => 'Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)' [patent_app_type] => B2 [patent_app_number] => 09/835217 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29695 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 781 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407127.pdf [firstpage_image] =>[orig_patent_app_number] => 09835217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6880475 [patent_doc_number] => 20010031762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-18 [patent_title] => 'Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)' [patent_app_type] => new [patent_app_number] => 09/834559 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30556 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20010031762.pdf [firstpage_image] =>[orig_patent_app_number] => 09834559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1463238 [patent_doc_number] => 06350873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-02-26 [patent_title] => 'Process for preparing 5-acetylstavudine' [patent_app_type] => B2 [patent_app_number] => 09/834028 [patent_app_country] => US [patent_app_date] => 2001-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2686 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350873.pdf [firstpage_image] =>[orig_patent_app_number] => 09834028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6628328 [patent_doc_number] => 20020016461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Biphenyl and biphenyl-analogous compounds as integrin antagonists' [patent_app_type] => new [patent_app_number] => 09/828514 [patent_app_country] => US [patent_app_date] => 2001-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55067 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20020016461.pdf [firstpage_image] =>[orig_patent_app_number] => 09828514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1065688 [patent_doc_number] => 06846814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-25 [patent_title] => 'Neurokinin antagonists for use as medicaments' [patent_app_type] => utility [patent_app_number] => 10/240852 [patent_app_country] => US [patent_app_date] => 2001-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15678 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/846/06846814.pdf [firstpage_image] =>[orig_patent_app_number] => 10240852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6410132 [patent_doc_number] => 20020038048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Catalytic asymmetric desymmetrization of meso compounds' [patent_app_type] => new [patent_app_number] => 09/825167 [patent_app_country] => US [patent_app_date] => 2001-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9468 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20020038048.pdf [firstpage_image] =>[orig_patent_app_number] => 09825167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7028727 [patent_doc_number] => 20010014680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-16 [patent_title] => '1,4-piperazine derivatives' [patent_app_type] => new [patent_app_number] => 09/822908 [patent_app_country] => US [patent_app_date] => 2001-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5586 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20010014680.pdf [firstpage_image] =>[orig_patent_app_number] => 09822908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5788510 [patent_doc_number] => 20020160980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Method of treating hepatitis delta virus infection' [patent_app_type] => new [patent_app_number] => 09/821278 [patent_app_country] => US [patent_app_date] => 2001-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17177 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160980.pdf [firstpage_image] =>[orig_patent_app_number] => 09821278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6408433 [patent_doc_number] => 20020037888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Inhibitors of prenyl-protein transferase' [patent_app_type] => new [patent_app_number] => 09/819522 [patent_app_country] => US [patent_app_date] => 2001-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57834 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037888.pdf [firstpage_image] =>[orig_patent_app_number] => 09819522 [rel_patent_id] =>[rel_patent_doc_number] =>)